CYT-0851 Phase 1 Dose Escalation Results Show Early Clinical Activity and Generally Well Tolerated Safety Profile in Advanced Solid Tumors and Hematologic Malignancies
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun 5, 2022--
More from West Virginia Business
West Virginia Executive Magazine
Tri-Share Child Care Program Now Open to Employers in All 55 West Virginia Counties
West Virginia Business
•
2d ago
West Virginia Executive Magazine
West Virginia Psychological Association Honors Dr. Casey Jo Cottrill with Award
West Virginia Business
•
Sep 25, 2026
West Virginia Executive Magazine
Sunbeams & Moonshine Creations to Display At WV Hive Booth at Bridge Day Celebration
West Virginia Business
•
Sep 16, 2026
West Virginia Executive Magazine
MN8 Energy, Google, and Eos Energy Enterprises Bring Advanced Clean Energy Solutions to West Virginia
West Virginia Business
•
Sep 3, 2026
West Virginia Executive Magazine
Seed Sower, Inc. Secures Federal and State Grants To Boost Its Recovery Mission
West Virginia Business
•
Sep 3, 2026